ICH Q3 Impurity Guidelines: Analytical Strategies for Safer Drug Development
Impurities in pharmaceuticals can compromise the safety, efficacy, and stability of a product. To safeguard public health, global...
Analytical Priorities in Drug Development: How Preclinical Data Shapes Regulatory Success
The preclinical research phase in the drug development process involves the extensive evaluation of candidate compounds before clinical...
Quality Control in Biotechnology: Ensuring Safety in the Biologics Manufacturing Process
The use of biologics has grown exponentially in the last decade, driven by advances in genetic engineering, a...
ICH Q3E Guideline: Impurities Assessment and Control
The safety and efficacy of pharmaceutical products largely depend on controlling impurities in their formulations. Therefore, the International...
ICH Guidelines: Drug Stability Testing Essentials
What Are ICH Guidelines? The ICH, a non-profit international organization founded in 1990, developed the ICH guidelines as...
Ozempic Impurities Explained: Ensuring Purity and Safety in Semaglutide-Based Therapies
Semaglutide has emerged as a groundbreaking therapy for managing type 2 diabetes, marketed under brand names like...
AMSbiopharma, Sponsor of the XIX Iberian Peptides Meeting (EPI 2025)
We are pleased to announce that AMSbiopharma will be an official sponsor of the XIX Iberian Peptides Meeting...
Peptide Drugs: Discovery and Development Explained
What Are Peptide Drugs and How Are They Used in Therapeutics? Peptide drugs, also known as therapeutic peptides,...